HomeAI · summaries
Storia in 15 fonti
Pharmalittle: We're reading about Trump's plan for tariffs on generics, a Merck and Gilead HIV pill, and more
President Trump plans to impose tariffs on imported generic medicines, his latest threat aimed at bringing pharmaceutical manufacturing back to the U.S.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Trump threatens tariffs on imported generic drugs
While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the…
- ·
supplychaindive.com
Trump maps out 200% tariffs for generic pharmaceuticals
The president said Tuesday he would maintain duty-free treatment for qualifying goods the next two years before hiking the tariffs in ensuing years.
- ·
timesofindia.indiatimes.com
Trump announces 0% tariff on generic medicines for two years; 200% thereafter
US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to enter the United States duty-free for two years…
- ·
economictimes.indiatimes.com
Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%
Trump has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.
- ·
benzinga.com
Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plan
Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.
- ·
newsbytesapp.com
Trump threatens tariff on generic medicines: Should India be worried?
US President Trump announced a two-year tariff exemption for imported generic medicines, warning of steep 200% duties if production doesn't shift to the US afterward.
- ·
cnbc.com
CNBC Daily Open: Generic problems, AI valuations and earnings on tap
President Trump takes fresh aim at the pharmaceutical sector, with a plan to levy 100% tariffs on generic drugs as he targets key areas ahead of the midterms.
- ·
independent.co.uk
Trump announces plan for 200% tariffs on imported generic drugs
Under the plan, announced on Truth Social, generic drugs imported into the U.S. would remain tariff-free for two years beginning Aug. 1
- ·
statnews.com
Pharmalittle: We're reading about Trump's plan for tariffs on generics, a Merck and Gilead HIV pill, and more
President Trump plans to impose tariffs on imported generic medicines, his latest threat aimed at bringing pharmaceutical manufacturing back to the U.S.
- ·
Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply
Trump's generic drug tariff plan raises questions over prices, U.S. manufacturing and which drugmakers stand to gain or lose as details remain unclear.
- ·
zerohedge.com
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners
"For our generics coverage, we view the group as relatively well-positioned given: AMRX (significant US infrastructure), TEVA..."
- ·
fiercepharma.com
Trump floats countdown to 200% tariffs on generic drugs imported to US
While the White House focused its initial Section 232 pharmaceutical tariffs on branded drugs, generics makers—who supply the vast majority of U.S. | While the White House focused…
- ·
cryptobriefing.com
Trump proposes 100% tariffs on imported generic drugs starting 2028, with 200% penalties to follow
Trump announces 100% tariffs on imported generic drugs starting August 2028, escalating to 200% in 2029, aiming to reshore US pharmaceutical
- ·
thehindu.com
Trump’s 200% generic tariff threat would imperil Americans: Indian pharma
Trump mandates U.S. generic drug production by 2028, imposing escalating tariffs on imports to boost domestic manufacturing.
- ·
commondreams.org
Patient Advocates Warn Trump Tariffs on Generic Drugs Could Drive Up Costs for Millions | Common Dreams
President Trump's plan to impose tariffs on imported generic drugs raises concerns among patient advocates.
- ·
cbsnews.com
Trump plans 100% tariffs on imported generic drugs. Here's what experts say.
Health policy experts say higher import duties could increase costs and strain supplies while offering no guarantee manufacturers will shift production to the U.S.